Interleukin-23 Antagonists [MoA] - N0000192798

Pharmacologic Code	N0000192798
Pharmacologic Name	Interleukin-23 Antagonists
Pharmacologic Uses	interleukin-23 antagonist
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 10 products whose active ingredient are classified under the same pharmacologic class Interleukin-23 Antagonists [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0002-7575	Omvoh	Non-Proprietary Name: Mirikizumab-mrkz	Injection, Solution	Intravenous	Eli Lilly And Company	ACTIVE
	0002-8011	Omvoh	Non-Proprietary Name: Mirikizumab-mrkz	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
	0074-1050	Skyrizi	Non-Proprietary Name: Risankizumab-rzaa	Injection	Subcutaneous	Abbvie Inc.	ACTIVE
	0074-2100	Skyrizi	Non-Proprietary Name: Risankizumab-rzaa	Injection	Subcutaneous	Abbvie Inc.	ACTIVE
	0074-5015	Skyrizi	Non-Proprietary Name: Risankizumab-rzaa	Injection	Intravenous	Abbvie Inc.	ACTIVE
	47335-177	Ilumya	Non-Proprietary Name: Tildrakizumab-asmn	Injection, Solution	Subcutaneous	Sun Pharmaceutical Industries, Inc.	ACTIVE
	57894-054	Stelara	Non-Proprietary Name: Ustekinumab	Solution	Intravenous	Janssen Biotech, Inc.	ACTIVE
	57894-060	Stelara	Non-Proprietary Name: Ustekinumab	Injection, Solution	Subcutaneous	Janssen Biotech, Inc.	ACTIVE
	57894-061	Stelara	Non-Proprietary Name: Ustekinumab	Injection, Solution	Subcutaneous	Janssen Biotech, Inc.	ACTIVE
	57894-640	Tremfya	Non-Proprietary Name: Guselkumab	Injection	Subcutaneous	Janssen Biotech, Inc.	ACTIVE